Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8

[1]  M. Wernli,et al.  Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. , 1998, The New England journal of medicine.

[2]  G. Gaidano,et al.  Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas) , 1998, Leukemia.

[3]  J. Aster,et al.  Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. , 1998, The New England journal of medicine.

[4]  T. Barbui,et al.  Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation. , 1998, Blood.

[5]  R. Warnke,et al.  Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. , 1998, Blood.

[6]  G. Gaidano,et al.  Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. , 1997, Blood.

[7]  G. Pinkus,et al.  Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. , 1997, Blood.

[8]  T. Barbui,et al.  The role of idarubicin in adult acute lymphoblastic leukaemia: from drug resistance studies to clinical application. , 1997, Leukemia & lymphoma.

[9]  E. Scanziani,et al.  A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice. , 1997, Leukemia research.

[10]  M. Moroni,et al.  Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. , 1997, Blood.

[11]  M. D. Boer,et al.  Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia , 1997, Leukemia.

[12]  G. Gaidano,et al.  HHV‐8‐POSITIVE BODY‐CAVITY‐BASED LYMPHOMA: A NOVEL LYMPHOMA ENTITY , 1997, British journal of haematology.

[13]  D. Ganem,et al.  Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. , 1997, The Journal of clinical investigation.

[14]  S. Swerdlow.  Post-transplant lymphoproliferative disorders: a working classification , 1997 .

[15]  P. Simmonds,et al.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen , 1996, The Lancet.

[16]  S. de Vos,et al.  Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. , 1996, Blood.

[17]  G. Gaidano,et al.  Kaposi's sarcoma‐associated herpesvirus DNA sequences in AIDS‐related and AIDS‐unrelated lymphomatous effusions , 1996, British journal of haematology.

[18]  E. Cesarman,et al.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. , 1996, Blood.

[19]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities. , 1996, The American journal of pathology.

[20]  M. Lehnert.  Clinical multidrug resistance in cancer: a multifactorial problem. , 1996, European journal of cancer.

[21]  L. Picker,et al.  Primary body cavity-based AIDS-related lymphomas. , 1996, American journal of clinical pathology.

[22]  O. Hermine,et al.  Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences. , 1996, The New England journal of medicine.

[23]  E. Kremmer,et al.  Bc16/Laz3 rearrangements in post‐transplant lymphoproliferative disorders , 1995, British journal of haematology.

[24]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[25]  C. Fisher,et al.  Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma , 1995, The Lancet.

[26]  J. Casanova,et al.  Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. , 1993, Leukemia.

[27]  J. Gribben,et al.  All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. , 1991, Blood.

[28]  G. Inghirami,et al.  Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. , 1989, Blood.

[29]  D. Karcher,et al.  Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus in organ transplant patients with immunosuppression. , 1997, British journal of haematology.

[30]  T. Barbui,et al.  Establishment and characterization of a new granulocyte-macrophage colony-stimulating factor-dependent and interleukin-3-dependent human acute myeloid leukemia cell line (GF-D8). , 1993, Blood.

[31]  E. Kieff,et al.  EPSTEIN-BARR VIRUS TYPE 1 (EBV-1) AND 2 (EBV-2) DIFFER IN THEIR EBNA-3A, EBNA-3B, AND EBNA-3C GENES , 1990 .